Reason for request

Renewal of inclusion

-


Clinical Benefit

Substantial

the actual benefit of CERVARIX remains substantial only the Marketing Authorisation indications recommended by the HCSP in the current vaccination schedule.


Contact Us

Évaluation des médicaments

See also